NeuroDerm Announces Removal of FDA Import Alert of Infusion

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
NeuroDerm Announces Removal of FDA Import Alert of Infusion Pumps Used in ND0612 Clinical Trials

REHOVOT, Israel, April 22, 2016 (GLOBE NEWSWIRE) -- NeuroDerm Ltd. (Nasdaq: NDRM ), a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) diseases, today announced that the Company has been informed by Canè S.p.A., the third party manufacturer of the infusion pumps used to deliver ND0612 in its current clinical trials, that they have been removed from the list of companies under import alert.  This latest regulatory action by the U. S. Food and Drug Administration (FDA), dated April 21, 2016, means that normal shipments to the US of devices from this manufacturer can now be resumed.

This import alert was enacted in July of 2015 when Canè S.p.A was issued a Warning Letter by the FDA requesting the manufacturer to provide additional documentation pertaining to good manufacturing practices of the Quality System regulation.  The manufacturer’s corrective actions and response to this Warning Letter have now been determined by the FDA to be apparently adequate, leading to the lifting of the import alert.  A Warning Letter close-out letter will be issued only after an FDA follow-up inspection will successfully verify that corrective actions have been implemented.  The timing of such inspection has yet to be determined.

NeuroDerm’s clinical development plan remains on track with its previously announced timelines both in the US and EU.

About NeuroDerm NeuroDerm is a clinical-stage pharmaceutical company developing central nervous system (CNS) product candidates that are designed to overcome major deficiencies of current treatments and achieve enhanced clinical efficacy through continuous, controlled administration.  The company has three product candidates in different stages of development which offer a solution for almost every Parkinson’s disease patient from the moderate to the very severe stage of the disease.  The company has developed a line of levodopa and carbidopa (LD/CD) product candidates administered through small belt pumps that deliver a continuous, controlled dose of LD/CD.  The LD/CD product candidates are ND0612L and ND0612H, which are used for treatment of moderate and advanced Parkinson’s disease patients, respectively, and which are delivered subcutaneously.  In addition, NeuroDerm is developing ND0701, a novel subcutaneously delivered apomorphine formulation for patients who suffer from moderate to severe Parkinson’s disease and who do not respond well to LD/CD.  NeuroDerm is headquartered in the Weizmann Science Park in Rehovot, Israel.

Forward-Looking Statements This press release contains forward-looking statements, within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended that involve risks and uncertainties. Such forward-looking statements may include projections regarding our future performance and may be identified by words like "anticipate," "assume," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "future," "will," "seek" and similar terms or phrases. The forward-looking statements contained in this press release are based on management's current expectations and projections about future events. There are important factors that could cause our actual results, levels of activity, performance or achievements to differ materially from the results, levels of activity, performance or achievements expressed or implied by the forward-looking statements. In particular, you should consider the risks provided under "Risk Factors" in our annual report on Form 20-F for the year ended December 31, 2015 filed with the Securities and Exchange Commission. Any forward-looking statement made by us in this press release speaks only as of the date hereof. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.

NeuroDerm Contact: Oded S. Lieberman, PhD MBA, CEO oded@neuroderm.com   Tel.: +972-8-946 2729 Cell: +1-617-517 6077

U.S. Investor Contact: David Carey Lazar Partners Ltd. dcarey@lazarpartners.com   +212-867-1768

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dario's Personify Panel Puts Distribution Model in Focus

Updated Category News Views 246

A Partner Megaphone Is Not a Revenue Line Monday's virtual panel gives DarioHealth a useful stage, but investors should not confuse a conference microphone with a signed sales order. Erez Raphael is set to lead a November 23 discussion with Personify Health President Ed Liebowitz at the U.S. Bancorp | BTIG Tech-Enabled Healthcare Forum, running from noon to 12:50 p.m....

Continue Reading
Fervo IPO Lawsuit Puts 71% Share Collapse in Focus

Updated Category News Views 53

Fervo’s $27 debut has turned into the sort of wreckage IPO buyers dread: shares were alleged to have closed as low as $7.79 when the complaint was filed. That is more than a 71% fall from the May 13, 2026 offering price, and it puts a hard, ugly number beside the new securities class action against the geothermal power developer. More Than a Bad Quarter Is Being Alleged...

Continue Reading
Align Wagner Collection Tests Men's Footwear Depth

Updated Category News Views 57

Three pairs of shoes are not a revolution, but they can expose whether a young brand has its footing. Align, established in 2025 by H.H. Brown, is rolling out the Wagner collection for Fall-Winter 2026 with a waterproof boot, a penny loafer and a lace-up oxford. That is a sensible little arsenal, not some overstuffed catalog dreamed up by a marketing committee that has...

Continue Reading
Tigerlily Brings HIV Information to Women’s Health

Updated Category News Views 60

A stubborn information gap is exactly where Tigerlily Foundation is planting its flag. The nonprofit’s new national HIV education and awareness campaign, THE POWER OF U, expands work that began in breast cancer advocacy into another area where women need clear facts, trusted voices, and room to speak without being shamed for needing answers. This is not a story that...

Continue Reading
PayPal's New Leadership Map Puts Execution on Trial

Updated Category News Views 106

Four senior appointments and a risk-chief exit can turn a tidy strategy slide into a very real operating test. PayPal has spent months defining three-year plans, simplifying its operating model and assigning clearer accountability; on November 20, it put names beside the jobs. For NASDAQ:PYPL investors, that is more consequential than another broad promise about...

Continue Reading
TCL CSOT's Oxide Leap Gives LCD a Sharper Fight Ahead

Updated Category News Views 73

Fifty-one point six is the number that makes this announcement worth chewing on. TCL CSOT says it has moved ultrahigh-mobility oxide technology into mass production on an 8.6-generation line, clearing the 50 cm² V?¹ s?¹ threshold that has largely belonged to lab-talk and presentation slides. For display people, that is not decorative science. It could change the old...

Continue Reading
OU's $44.3M Rural Care Plan Targets Oklahoma Care Gaps

Updated Category News Views 70

A Long Drive Is a Brutal Barrier to Care Seventy-five of Oklahoma's 77 counties sit in health professional shortage territory, a figure that ought to stop people cold. It means at least 3,500 patients per provider in those counties. That is not some abstract planning headache. It is the pregnant patient delaying a specialist visit, the family weighing an ambulance ride,...

Continue Reading
Surfcomber Uses Art Week to Deepen Its Guest Appeal

Updated Category News Views 77

Miami Art Week can turn every hotel lobby into a billboard, but Surfcomber is at least trying to make its walls do some actual work. Kimpton Surfcomber Hotel is spreading local artists, participatory events, food, cocktails and retail across the property rather than hanging a few paintings and calling it culture. For a South Beach hotel with 200 feet of oceanfront, that...

Continue Reading
PPL's January Dividend Keeps Utility Appeal Intact

Updated Category News Views 125

A dividend notice is rarely thrilling, but it can still separate a steady utility from a story stock peddling fumes. PPL Corporation declared a quarterly common dividend of $0.2850 per share on Nov. 20, payable Jan. 4, 2027. Shareholders must be on the books by Dec. 10, 2026, to receive it. Plain vanilla stuff, yes. Still, plain vanilla is often precisely why utility...

Continue Reading
University of Phoenix Poll Gets a Useful Reality Check

Updated Category News Views 89

Good Numbers, With the Usual Fine Print Employer approval is the kind of evidence career-focused schools desperately need, and University of Phoenix just put up a pretty loud batch of it. Among managers who directly supervise its graduates, 94% said the university understands employer needs, while 92% said its programs align with workforce demands. Those are stout...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming Physician Compensation Management at Southwell

Updated Category News Views 112

Revolutionizing Physician Compensation with Clinician Nexus In a significant move towards streamlining physician compensation processes, Southwell, a notable health system in South Central Georgia, has partnered with Clinician Nexus, a leader in clinical workforce technology. This collaboration will introduce Clinician Nexus’ advanced physician compensation management...

Continue Reading
Transforming a $1000 Investment in Digital Realty Trust Today

Updated Category News Views 208

Long-Term Investing Success with Digital Realty Trust Digital Realty Trust (NYSE: DLR) has shown remarkable performance in the financial markets, surpassing typical market returns consistently over the last two decades. With an impressive annualized return of 11.8%, this company has proven its capability to deliver value to its investors. The Growth of Your Initial...

Continue Reading
Investigation Launched on Markforged Shareholder Deal Fairness

Updated Category News Views 89

So here’s the scoop: Ademi LLP has kicked off an investigation into Markforged Holding Corporation (NYSE: MKFG), and it’s not just for show. The focus? To unpack whether the company’s board is doing their job right in a deal that smells a bit fishy with Nano Dimension. A Stinky Deal Under this agreement, shareholders are looking at a measly $5.00 per share—sounds...

Continue Reading
Introducing Noel Ortega: A Transformative Leader at SAFCO

Updated Category News Views 179

SAFCO Welcomes New Leadership in Account Services Southern Auto Finance Company, LLC (SAFCO) is thrilled to announce that Noel Ortega has been appointed as the new Senior Vice President of Account Services. Mr. Ortega comes with a wealth of knowledge from over 20 years in the auto finance sector, emphasizing collections and outstanding customer service. Mr. Ortega's...

Continue Reading
BBG Expands Services with New Data Center Specialty Practice

Updated Category News Views 167

BBG Unveils New Data Center Specialty Practice BBG, a prominent figure in the national commercial real estate services arena, has recently launched a dedicated Data Center Specialty Practice to address the surging demand for valuation and advisory services within the mission-critical infrastructure domain. Leading the charge is Christopher M. Fudacz, a seasoned expert in...

Continue Reading